R. Kridel, L. Sehn, and R. Gascoyne, Pathogenesis of follicular lymphoma, Journal of Clinical Investigation, vol.122, issue.10, pp.3424-3455, 2012.
DOI : 10.1172/JCI63186

S. Montoto, A. Davies, J. Matthews, M. Calaminici, A. Norton et al., Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Journal of Clinical Oncology, vol.25, issue.17, pp.2426-2459, 2007.
DOI : 10.1200/JCO.2006.09.3260

A. Shaffer, R. Young, and L. Staudt, Pathogenesis of Human B Cell Lymphomas, Annual Review of Immunology, vol.30, issue.1, pp.565-610, 2012.
DOI : 10.1146/annurev-immunol-020711-075027

S. Roulland, M. Faroudi, E. Mamessier, S. Sungalee, G. Salles et al., Early Steps of Follicular Lymphoma Pathogenesis, Advances in immunology, vol.111, pp.1-46, 2011.
DOI : 10.1016/B978-0-12-385991-4.00001-5
URL : https://hal.archives-ouvertes.fr/hal-00672189

M. Green, A. Gentles, R. Nair, J. Irish, S. Kihira et al., Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma, Blood, vol.121, issue.9, pp.1604-1615, 2013.
DOI : 10.1182/blood-2012-09-457283

A. Carbone, A. Gloghini, A. Cabras, and G. Elia, The Germinal centre-derived lymphomas seen through their cellular microenvironment, British Journal of Haematology, vol.111, issue.4, pp.468-80, 2009.
DOI : 10.1111/j.1365-2141.2009.07651.x

F. Vega, L. Medeiros, W. Lang, A. Mansoor, C. Bueso-ramos et al., The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours, British Journal of Haematology, vol.26, issue.3, pp.569-76, 2002.
DOI : 10.1038/364645a0

H. Rajnai, C. Bodor, Z. Balogh, E. Gagyi, J. Csomor et al., Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma, Histopathology, vol.104, issue.6B, pp.66-75, 2012.
DOI : 10.1111/j.1365-2559.2012.04187.x

A. Bognar, B. Csernus, C. Bodor, L. Reiniger, A. Szepesi et al., Clonal selection in the bone marrow involvement of follicular lymphoma, Leukemia, vol.160, issue.9, pp.1656-62, 2005.
DOI : 10.1038/sj.leu.2403844

P. Ruminy, F. Jardin, J. Picquenot, F. Parmentier, N. Contentin et al., S?? mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells, Blood, vol.112, issue.5, pp.1951-1960, 2008.
DOI : 10.1182/blood-2007-11-124560

M. Wartenberg, P. Vasil, M. Z. Bueschenfelde, C. Ott, G. Rosenwald et al., Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse, Haematologica, vol.98, issue.9, 2013.
DOI : 10.3324/haematol.2012.074252

E. Launay, C. Pangault, P. Bertrand, F. Jardin, T. Lamy et al., High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis, Leukemia, vol.24, issue.3, pp.559-62, 2012.
DOI : 10.1038/leu.2011.266
URL : https://hal.archives-ouvertes.fr/hal-00869037

C. Pasero, D. Speiser, L. Derre, and D. Olive, The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy, Current Opinion in Pharmacology, vol.12, issue.4, pp.478-85, 2012.
DOI : 10.1016/j.coph.2012.03.001

F. Stevenson and G. Stevenson, Follicular lymphoma and the immune system: from pathogenesis to antibody therapy, Blood, vol.119, issue.16, pp.3659-67, 2012.
DOI : 10.1182/blood-2011-11-367730

V. Coelho, S. Krysov, A. Ghaemmaghami, M. Emara, K. Potter et al., Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins, Proceedings of the National Academy of Sciences, vol.107, issue.43, pp.18587-92, 2010.
DOI : 10.1073/pnas.1009388107

T. Relander, N. Johnson, P. Farinha, J. Connors, L. Sehn et al., Prognostic Factors in Follicular Lymphoma, Journal of Clinical Oncology, vol.28, issue.17, pp.2902-2915, 2010.
DOI : 10.1200/JCO.2009.26.1693

S. Dave, G. Wright, B. Tan, A. Rosenwald, R. Gascoyne et al., Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells, New England Journal of Medicine, vol.351, issue.21, pp.2159-69, 2004.
DOI : 10.1056/NEJMoa041869

D. Nicola, M. Zappasodi, R. Carlo-stella, C. Mortarini, R. Pupa et al., Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study, Blood, vol.113, issue.1, pp.18-27, 2009.
DOI : 10.1182/blood-2008-06-165654

S. Hilchey, O. Hyrien, T. Mosmann, A. Livingstone, J. Friedberg et al., Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab, Blood, vol.113, issue.16, pp.3809-3821, 2009.
DOI : 10.1182/blood-2008-10-185280

M. Bendandi, Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures, Nature Reviews Cancer, vol.2, issue.9, pp.675-81, 2009.
DOI : 10.1038/nrc2717

S. Horning and S. Rosenberg, The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas, New England Journal of Medicine, vol.311, issue.23, pp.1471-1476, 1984.
DOI : 10.1056/NEJM198412063112303

T. Alvaro, M. Lejeune, M. Salvado, C. Lopez, J. Jaen et al., Immunohistochemical Patterns of Reactive Microenvironment Are Associated With Clinicobiologic Behavior in Follicular Lymphoma Patients, Journal of Clinical Oncology, vol.24, issue.34, pp.5350-5357, 2006.
DOI : 10.1200/JCO.2006.06.4766

B. Wahlin, C. Sundstrom, H. Holte, H. Hagberg, M. Erlanson et al., T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab, Clinical Cancer Research, vol.17, issue.12, pp.4136-4180, 2011.
DOI : 10.1158/1078-0432.CCR-11-0264

C. Laurent, S. Muller, C. Do, T. Saati, S. Allart et al., Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study, Blood, vol.118, issue.20, pp.5371-5380, 2011.
DOI : 10.1182/blood-2011-04-345777

Z. Yang, D. Grote, S. Ziesmer, T. Niki, M. Hirashima et al., IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma, Journal of Clinical Investigation, vol.122, issue.4, pp.1271-82, 2012.
DOI : 10.1172/JCI59806DS1

Z. Yang, A. Novak, S. Ziesmer, T. Witzig, and S. Ansell, Attenuation of CD8+ T-Cell Function by CD4+CD25+ Regulatory T Cells in B-Cell Non-Hodgkin's Lymphoma, Cancer Research, vol.66, issue.20, pp.10145-52, 2006.
DOI : 10.1158/0008-5472.CAN-06-1822

S. Lee, R. Srivastava, A. Lopez-albaitero, S. Ferrone, and R. Ferris, Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity, Immunologic Research, vol.185, issue.11, pp.248-54, 2011.
DOI : 10.1007/s12026-011-8231-0

M. Braza, B. Klein, G. Fiol, and J. Rossi, ???? T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody, Haematologica, vol.96, issue.3, pp.400-407, 2011.
DOI : 10.3324/haematol.2010.029520

M. Brandes, K. Willimann, A. Lang, K. Nam, J. C. Brenner et al., Flexible migration program regulates ???? T-cell involvement in humoral immunity, Blood, vol.102, issue.10, pp.3693-701, 2003.
DOI : 10.1182/blood-2003-04-1016

M. Braza, A. Caraux, T. Rousset, L. De-micheaux, S. Sicard et al., ???? T Lymphocytes Count Is Normal and Expandable in Peripheral Blood of Patients with Follicular Lymphoma, Whereas It Is Decreased in Tumor Lymph Nodes Compared with Inflammatory Lymph Nodes, The Journal of Immunology, vol.184, issue.1, pp.134-174, 2010.
DOI : 10.4049/jimmunol.0901980

J. Gertner-dardenne, C. Fauriat, F. Orlanducci, M. Thibult, S. Pastor et al., The co-receptor BTLA negatively regulates human Vgamma9Vdelta2 T cell proliferation: a potential way of immune escape for lymphoma cells, Blood, 2013.

S. Catellani, A. Poggi, A. Bruzzone, P. Dadati, J. Ravetti et al., Expansion of V??1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins, Blood, vol.109, issue.5, pp.2078-85, 2007.
DOI : 10.1182/blood-2006-06-028985

G. Cartron, L. Dacheux, G. Salles, P. Solal-celigny, P. Bardos et al., Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fcgamma RIIIa gene, Blood, vol.99, issue.3, pp.754-762, 2002.
DOI : 10.1182/blood.V99.3.754

P. Farinha, H. Masoudi, B. Skinnider, K. Shumansky, J. Spinelli et al., Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL), Blood, vol.106, issue.6, pp.2169-74, 2005.
DOI : 10.1182/blood-2005-04-1565

D. Canioni, G. Salles, N. Mounier, N. Brousse, M. Keuppens et al., High Numbers of Tumor-Associated Macrophages Have an Adverse Prognostic Value That Can Be Circumvented by Rituximab in Patients With Follicular Lymphoma Enrolled Onto the GELA-GOELAMS FL-2000 Trial, Journal of Clinical Oncology, vol.26, issue.3, pp.440-446, 2008.
DOI : 10.1200/JCO.2007.12.8298

M. Taskinen, M. Karjalainen-lindsberg, H. Nyman, L. Eerola, and S. Leppa, A High Tumor-Associated Macrophage Content Predicts Favorable Outcome in Follicular Lymphoma Patients Treated with Rituximab and Cyclophosphamide-Doxorubicin-Vincristine-Prednisone, Clinical Cancer Research, vol.13, issue.19, pp.5784-5793, 2007.
DOI : 10.1158/1078-0432.CCR-07-0778

V. Minard-colin, Y. Xiu, J. Poe, M. Horikawa, C. Magro et al., Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc??RI, Fc??RIII, and Fc??RIV, Blood, vol.112, issue.4, pp.1205-1218, 2008.
DOI : 10.1182/blood-2008-01-135160

O. Manches, G. Lui, L. Chaperot, R. Gressin, J. Molens et al., In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas, Blood, vol.101, issue.3, pp.949-54, 2003.
DOI : 10.1182/blood-2002-02-0469

S. Rafiq, J. Butchar, C. Cheney, X. Mo, R. Trotta et al., Comparative Assessment of Clinically Utilized CD20-Directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK Cell, Monocyte, and Macrophage Properties, The Journal of Immunology, vol.190, issue.6, pp.2702-2713, 2013.
DOI : 10.4049/jimmunol.1202588

M. Leidi, E. Gotti, L. Bologna, E. Miranda, M. Rimoldi et al., M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro, The Journal of Immunology, vol.182, issue.7, pp.4415-4437, 2009.
DOI : 10.4049/jimmunol.0713732

Y. Liu, E. Masuda, M. Blank, K. Kirou, X. Gao et al., Cytokine-mediated regulation of activating and inhibitory Fc?? receptors in human monocytes, Journal of Leukocyte Biology, vol.77, issue.5, pp.767-76, 2005.
DOI : 10.1189/jlb.0904532

M. Chao, A. Alizadeh, C. Tang, J. Myklebust, B. Varghese et al., Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma, Cell, vol.142, issue.5, pp.699-713, 2010.
DOI : 10.1016/j.cell.2010.07.044

L. Wu, M. Adams, T. Carter, R. Chen, G. Muller et al., Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells, Clinical Cancer Research, vol.14, issue.14, pp.4650-4657, 2008.
DOI : 10.1158/1078-0432.CCR-07-4405

A. Lopez-girona, D. Mendy, T. Ito, K. Miller, A. Gandhi et al., Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide, Leukemia, vol.96, issue.11, pp.2326-2361, 2012.
DOI : 10.1002/tera.1420270306

A. Ramsay, R. Evans, S. Kiaii, L. Svensson, N. Hogg et al., Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide, Blood, vol.121, issue.14, pp.2704-2718, 2013.
DOI : 10.1182/blood-2012-08-448332

J. Desjarlais and G. Lazar, Modulation of antibody effector function, Experimental Cell Research, vol.317, issue.9, pp.1278-85, 2011.
DOI : 10.1016/j.yexcr.2011.03.018

J. Richards, S. Karki, G. Lazar, H. Chen, W. Dang et al., Optimization of antibody binding to Fc??RIIa enhances macrophage phagocytosis of tumor cells, Molecular Cancer Therapeutics, vol.7, issue.8, pp.2517-2544, 2008.
DOI : 10.1158/1535-7163.MCT-08-0201

R. Houot, H. Kohrt, A. Marabelle, and R. Levy, Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy, Trends in Immunology, vol.32, issue.11, pp.510-516, 2011.
DOI : 10.1016/j.it.2011.07.003
URL : https://hal.archives-ouvertes.fr/hal-00744044

H. Kohrt, R. Houot, M. Goldstein, K. Weiskopf, A. Alizadeh et al., CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies, CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies, pp.2423-2455, 2011.
DOI : 10.1182/blood-2010-08-301945
URL : https://hal.archives-ouvertes.fr/hal-00743985

F. Romagne, P. Andre, P. Spee, S. Zahn, N. Anfossi et al., Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells, Blood, vol.114, issue.13, pp.2667-77, 2009.
DOI : 10.1182/blood-2009-02-206532
URL : https://hal.archives-ouvertes.fr/hal-00431858

M. Braza and B. Klein, Anti-tumour immunotherapy with V??9V??2 T lymphocytes: from the bench to the bedside, British Journal of Haematology, vol.99, issue.2, pp.123-155, 2013.
DOI : 10.1111/bjh.12090

D. Hanahan and L. Coussens, Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment, Cancer Cell, vol.21, issue.3, pp.309-331, 2012.
DOI : 10.1016/j.ccr.2012.02.022

S. Mueller and R. Germain, Stromal cell contributions to the homeostasis and functionality of the immune system, Nature Reviews Immunology, vol.171, pp.618-647, 2009.
DOI : 10.1038/nri2588

R. Roozendaal and R. Mebius, Stromal Cell???Immune Cell Interactions, Annual Review of Immunology, vol.29, issue.1, pp.23-43, 2011.
DOI : 10.1146/annurev-immunol-031210-101357

S. Maugendre, Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis, Blood, vol.109, pp.693-702, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00697066

V. Thomazy, F. Vega, L. Medeiros, P. Davies, and D. Jones, Phenotypic Modulation of the Stromal Reticular Network in Normal and Neoplastic Lymph Nodes, The American Journal of Pathology, vol.163, issue.1, pp.165-74, 2003.
DOI : 10.1016/S0002-9440(10)63640-1

K. Chang, X. Huang, L. Medeiros, and D. Jones, Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma, The Journal of Pathology, vol.198, issue.3, pp.404-416, 2003.
DOI : 10.1002/path.1478

M. Jin, E. Hoster, M. Dreyling, M. Unterhalt, W. Hiddemann et al., Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome, Histopathology, vol.114, issue.4, pp.586-92, 2011.
DOI : 10.1111/j.1365-2559.2011.03779.x
URL : https://hal.archives-ouvertes.fr/hal-00623321

F. Guilloton, G. Caron, C. Ménard, C. Pangault, P. Amé-thomas et al., Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes, Blood, vol.119, issue.11, pp.2556-67, 2012.
DOI : 10.1182/blood-2011-08-370908
URL : https://hal.archives-ouvertes.fr/inserm-00665887

K. Yagi, K. Yamamoto, S. Umeda, S. Abe, S. Suzuki et al., gene in B-cell lymphomas: association with follicular dendritic cells, Histopathology, vol.15, issue.3, pp.414-434, 2013.
DOI : 10.1111/his.12035

R. Sacedon, B. Diez, V. Nunez, C. Hernandez-lopez, C. Gutierrez-frias et al., Sonic Hedgehog Is Produced by Follicular Dendritic Cells and Protects Germinal Center B Cells from Apoptosis, The Journal of Immunology, vol.174, issue.3, pp.1456-61, 2005.
DOI : 10.4049/jimmunol.174.3.1456

C. Dierks, J. Grbic, K. Zirlik, R. Beigi, N. Englund et al., Essential role of stromally induced hedgehog signaling in B-cell malignancies, Nature Medicine, vol.8, issue.8, pp.944-51, 2007.
DOI : 10.1038/nm1614

C. Park, S. Yoon, R. Armitage, and Y. Choi, Follicular Dendritic Cells Produce IL-15 That Enhances Germinal Center B Cell Proliferation in Membrane-Bound Form, The Journal of Immunology, vol.173, issue.11, pp.6676-83, 2004.
DOI : 10.4049/jimmunol.173.11.6676

G. Epron, P. Ame-thomas, L. Priol, J. Pangault, C. Dulong et al., Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling, Leukemia, vol.91, issue.1, pp.139-187, 2012.
DOI : 10.1016/j.cell.2010.07.044
URL : https://hal.archives-ouvertes.fr/inserm-00869028

E. Tjin, R. Bende, P. Derksen, A. Van-huijstee, H. Kataoka et al., Follicular Dendritic Cells Catalyze Hepatocyte Growth Factor (HGF) Activation in the Germinal Center Microenvironment by Secreting the Serine Protease HGF Activator, The Journal of Immunology, vol.175, issue.5, pp.2807-2820, 2005.
DOI : 10.4049/jimmunol.175.5.2807

E. Tjin, R. Groen, I. Vogelzang, P. Derksen, M. Klok et al., Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma, Blood, vol.107, issue.2, pp.760-768, 2006.
DOI : 10.1182/blood-2005-05-1929

C. Mueller, C. Boix, W. Kwan, C. Daussy, E. Fournier et al., Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation, Journal of Leukocyte Biology, vol.82, issue.3, pp.567-75, 2007.
DOI : 10.1189/jlb.0706481
URL : https://hal.archives-ouvertes.fr/hal-00165353

T. Lwin, L. Crespo, A. Wu, S. Dessureault, H. Shu et al., Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis, Leukemia, vol.107, issue.1, pp.170-177, 2009.
DOI : 10.1038/leu.2008.266

R. Singh, J. Kim, Y. Davuluri, E. Drakos, J. Cho-vega et al., Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation, Leukemia, vol.174, issue.5, pp.1025-1061, 2010.
DOI : 10.1111/j.1365-2141.2008.07176.x

M. Mraz, C. Zent, A. Church, D. Jelinek, X. Wu et al., Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin ??-4-??-1 (VLA-4) with natalizumab can overcome this resistance, British Journal of Haematology, vol.69, issue.1, pp.53-64, 2011.
DOI : 10.1111/j.1365-2141.2011.08794.x

A. Roccaro, A. Sacco, P. Maiso, A. Azab, Y. Tai et al., BM mesenchymal stromal cell???derived exosomes facilitate multiple myeloma progression, Journal of Clinical Investigation, vol.123, issue.4, pp.1542-55, 2013.
DOI : 10.1172/JCI66517DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613927

W. Zhang, D. Trachootham, J. Liu, G. Chen, H. Pelicano et al., Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia, Nature Cell Biology, vol.17, issue.3, pp.276-86, 2012.
DOI : 10.1038/ncb2432

G. Ren, X. Zhao, Y. Wang, X. Zhang, X. Chen et al., CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNF??, Cell Stem Cell, vol.11, issue.6, pp.812-836, 2012.
DOI : 10.1016/j.stem.2012.08.013

M. Hajjami, H. Ame-thomas, P. Pangault, C. Tribut, O. Devos et al., Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase, Cancer Research, vol.69, issue.7, pp.3228-3265, 2009.
DOI : 10.1158/0008-5472.CAN-08-3000
URL : https://hal.archives-ouvertes.fr/inserm-00869384

V. Lukacs-kornek, D. Malhotra, A. Fletcher, S. Acton, K. Elpek et al., Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes, Nature Immunology, vol.176, issue.11, pp.1096-104, 2011.
DOI : 10.1084/jem.193.11.1261

J. Myklebust, J. Irish, J. Brody, D. Czerwinski, R. Houot et al., High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells, Blood, vol.121, issue.8, pp.1367-76, 2013.
DOI : 10.1182/blood-2012-04-421826

S. Hilchey, A. Rosenberg, O. Hyrien, S. Secor-socha, M. Cochran et al., Follicular lymphoma tumor-infiltrating T-helper (TH) cells have the same polyfunctional potential as normal nodal TH cells despite skewed differentiation, Blood, vol.118, issue.13, pp.3591-602, 2011.
DOI : 10.1182/blood-2011-03-340646

N. Fazilleau, L. Mark, L. Mcheyzer-williams, and M. Mcheyzer-williams, Follicular Helper T Cells: Lineage and Location, Immunity, vol.30, issue.3, pp.324-359, 2009.
DOI : 10.1016/j.immuni.2009.03.003

P. Amé-thomas, L. Priol, J. Yssel, H. Caron, G. Pangault et al., Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells, Leukemia, vol.24, issue.5, pp.1053-63, 2012.
DOI : 10.1038/leu.2011.301

K. Calvo, B. Dabir, A. Kovach, C. Devor, R. Bandle et al., IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma, Blood, vol.112, issue.9, pp.3818-3844, 2008.
DOI : 10.1182/blood-2008-02-138933

V. Gocheva, H. Wang, B. Gadea, T. Shree, K. Hunter et al., IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion, Genes & Development, vol.24, issue.3, pp.241-55, 2010.
DOI : 10.1101/gad.1874010

Z. Yang, A. Novak, M. Stenson, T. Witzig, and S. Ansell, Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma, Blood, vol.107, issue.9, pp.3639-3685, 2006.
DOI : 10.1182/blood-2005-08-3376

P. Farinha, A. Tourah, K. Gill, R. Klasa, J. Connors et al., The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation, Blood, vol.115, issue.2, pp.289-95, 2010.
DOI : 10.1182/blood-2009-07-235598

L. Strauss, C. Bergmann, M. Szczepanski, S. Lang, J. Kirkwood et al., Expression of ICOS on Human Melanoma-Infiltrating CD4+CD25highFoxp3+ T Regulatory Cells: Implications and Impact on Tumor-Mediated Immune Suppression, The Journal of Immunology, vol.180, issue.5
DOI : 10.4049/jimmunol.180.5.2967

A. Novak, D. Grote, M. Stenson, S. Ziesmer, T. Witzig et al., Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome, Blood, vol.104, issue.8, pp.2247-53, 2004.
DOI : 10.1182/blood-2004-02-0762

A. Novak, S. Slager, Z. Fredericksen, A. Wang, M. Manske et al., Genetic Variation in B-Cell-Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma, Cancer Research, vol.69, issue.10, pp.4217-4241, 2009.
DOI : 10.1158/0008-5472.CAN-08-4915

J. Hildebrand, Z. Luo, M. Manske, T. Price-troska, S. Ziesmer et al., A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling, The Journal of Experimental Medicine, vol.65, issue.12, pp.2569-79, 2010.
DOI : 10.1038/ni.1676

K. Sachen, M. Strohman, J. Singletary, A. Alizadeh, N. Kattah et al., Self-antigen recognition by follicular lymphoma B-cell receptors, Blood, vol.120, issue.20, pp.4182-90, 2012.
DOI : 10.1182/blood-2012-05-427534
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501716

F. Aguado and M. Corcuera, Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10, J Immunol, vol.186, pp.2192-200, 2011.

M. Zhang, Z. Yao, S. Dubois, W. Ju, J. Muller et al., Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer, Proceedings of the National Academy of Sciences, vol.106, issue.18, pp.7513-7521, 2009.
DOI : 10.1073/pnas.0902637106

X. Hu, K. Park-min, H. Ho, and L. Ivashkiv, IFN-??-Primed Macrophages Exhibit Increased CCR2-Dependent Migration and Altered IFN-?? Responses Mediated by Stat1, The Journal of Immunology, vol.175, issue.6, pp.3637-3684, 2005.
DOI : 10.4049/jimmunol.175.6.3637

A. Carbonnelle-puscian, C. Copie-bergman, M. Baia, N. Martin-garcia, Y. Allory et al., The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages, Leukemia, vol.29, issue.5, pp.952-60, 2009.
DOI : 10.1038/leu.2008.380
URL : https://hal.archives-ouvertes.fr/inserm-00392067

A. Clear, A. Lee, M. Calaminici, A. Ramsay, K. Morris et al., Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment, Blood, vol.115, issue.24, pp.5053-5059, 2010.
DOI : 10.1182/blood-2009-11-253260

C. Immunosuppressive, -monocytes in B-cell non-Hodgkin lymphoma, Blood, vol.117, pp.872-81, 2011.

R. Wilcox, K. Ristow, T. Habermann, D. Inwards, I. Micallef et al., The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma, Leukemia & Lymphoma, vol.67, issue.4, pp.575-80, 2012.
DOI : 10.1111/j.1365-2141.2007.06615.x

Y. Hu, M. Gale, J. Shields, C. Garron, M. Swistak et al., Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists, Leukemia & Lymphoma, vol.62, issue.1, pp.130-138, 2012.
DOI : 10.1016/S1074-7613(03)00263-2

O. Callaghan, K. Lee, L. Nguyen, N. Hsieh, M. Kaneider et al., Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia, Blood, vol.119, issue.7, pp.1717-1742, 2012.
DOI : 10.1182/blood-2011-04-347518

M. De-rooij, A. Kuil, C. Geest, E. Eldering, B. Chang et al., The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia, Blood, vol.119, issue.11, pp.2590-2594, 2012.
DOI : 10.1182/blood-2011-11-390989

J. Hoellenriegel, S. Meadows, M. Sivina, W. Wierda, H. Kantarjian et al., The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia, Blood, vol.118, issue.13, pp.3603-3615, 2011.
DOI : 10.1182/blood-2011-05-352492

M. Wobus, G. Benath, R. Ferrer, R. Wehner, M. Schmitz et al., Impact of lenalidomide on the functional properties of human mesenchymal stromal cells, Experimental Hematology, vol.40, issue.10, pp.867-76, 2012.
DOI : 10.1016/j.exphem.2012.06.004

A. Troeger, A. Johnson, J. Wood, W. Blum, L. Andritsos et al., RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans, Blood, vol.119, issue.20, pp.4708-4726, 2012.
DOI : 10.1182/blood-2011-12-395939

J. Ruan, M. Luo, C. Wang, L. Fan, S. Yang et al., Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes, Blood, vol.121, issue.26, pp.5192-202, 2013.
DOI : 10.1182/blood-2013-03-490763

M. Sznol and L. Chen, Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer, Clinical Cancer Research, vol.19, issue.5, pp.1021-1055, 2013.
DOI : 10.1158/1078-0432.CCR-12-2063

P. Sage, L. Francisco, C. Carman, and A. Sharpe, The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood, Nature Immunology, vol.179, issue.2, pp.152-61, 2013.
DOI : 10.1084/jem.20021603

R. Cubas, J. Mudd, A. Savoye, M. Perreau, J. Van-grevenynghe et al., Inadequate T follicular cell help impairs B cell immunity during HIV infection, Nature Medicine, vol.110, issue.4, pp.494-503, 2013.
DOI : 10.1038/nm.3109

Z. Yang, A. Novak, S. Ziesmer, T. Witzig, and S. Ansell, Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma, Cancer Research, vol.69, issue.13, pp.5522-5552, 2009.
DOI : 10.1158/0008-5472.CAN-09-0266

Z. Yang, A. Novak, S. Ziesmer, T. Witzig, and S. Ansell, CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells, Blood, vol.110, issue.7, pp.2537-2581, 2007.
DOI : 10.1182/blood-2007-03-082578

A. Ramsay, A. Clear, R. Fatah, and J. Gribben, Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer, Blood, vol.120, issue.7, pp.1412-1433, 2012.
DOI : 10.1182/blood-2012-02-411678

M. Linterman and C. Vinuesa, Signals that influence T follicular helper cell differentiation and function, Seminars in Immunopathology, vol.72, issue.2, pp.183-96, 2010.
DOI : 10.1007/s00281-009-0194-z
URL : http://hdl.handle.net/1885/64100

H. Xu, X. Li, D. Liu, J. Li, X. Zhang et al., Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility, Nature, vol.21, issue.7446, pp.523-530, 2013.
DOI : 10.1038/nature12058